Search results for "ATC|VARIOUS|THERAPEUTIC RADIOPHARMACEUTICALS" in comments (approximate match)
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Lutetium Lu 177 dotatate binds to somatostatin receptors with highest affinity for subtype 2 receptors (SSRT2). Upon binding to somatostatin
receptor expressing cells, including malignant somatostatin receptor-positive tumors, the compound is interna...
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Iobenguane I-131 is a radioactive therapeutic agent. The drug contains radioactive isotope I-131, which decays by electron emission with a half-life of about 8 days. By the chemical structure, iobenguane is similar to the neurotransmitter norepinephr...
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Strontium SR-89 is a radioactive isotope of strontium. Strontium-89 decays by beta emission with a half-life of 50.5 days. Beta-particles produced by radioactive decay penetrate tissues at a range of approximately 8 mm. Strontium SR-89 is used in med...
The therapeutic use of radioactive colloidal gold Gold Au-198 (Au198) was first described by Sheppard et al., who reported on intravenous use in 1947. Its possibilities for the treatment of various malignant processes have been explored in great vari...
Erbium-169 citrate is anti-inflammatory and antirheumatic radiopharmaceutical agent. Erbium-169 decays with half-life 9.4 days by the emission of beta particle and very low energy gamma radiation. The average radiation penetration is 0.3 mm in the so...
YTTRIUM Y-90 (YTRACIS®, YTTRIGA®) is a radioactive form of the chemical element yttrium. It is used for radiolabelling other medicines. An example of its use is the treatment of some type of tumors, where the radiolabelled medicine carries the radioa...
